Tripping for depressionTripping for depression
All In The Mind
In 1966, as a reaction to disturbing reports of people having bad trips, the psychedelic drug LSD was banned in the U.S. Now some scientists are seeing promising results from studies into the therapeutic benefits of using psychedelic drugs to treat mental illness.
29:05•4 Aug 2019
Psychedelics and Mental Health: Breaking the Stigma
“It appears that it is such a profound effect even on the personality of somebody.”
What if the key to mental wellness lies in a substance once shunned by society? This episode of 'All In The Mind' dives into the intriguing world of psychedelic drugs and their potential benefits for treating mental illness. Back in 1966, LSD was banned in the U.S. due to alarming reports of bad trips. Fast forward to today, and some scientists are seeing promising results from studies on psychedelics as therapeutic tools.
The episode kicks off with a brief history of these drugs and the reasons behind their prohibition. Host Lynne Malcolm then brings in experts like Rick Doblin, Amanda Fielding, David Arezzo, and Vince Pelito to share their experiences and insights. They emphasize the importance of a safe and controlled environment for psychedelic experiences. The discussion also touches on the Beckley Imperial Research Program's findings on LSD, revealing its potential to reduce distractibility and increase control.
However, the conversation doesn't shy away from the limitations of current studies and the need for further research. If you're curious about how psychedelics might change the future of mental health treatment, this episode is a must-listen.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.